How to interpret data from the superficial femoral artery stenting trials and registries

Seminars in Vascular Surgery

Volumn 23, Issue 3, 2010, Pages 138-147

  Lin, Peter H ^a   Weakley, Sarah M ^a   Kougias, Panagiotis ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; NITINOL; PACLITAXEL; RAPAMYCIN;

ARTICLE; BARE METAL STENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL; DATA ANALYSIS; DISEASE CLASSIFICATION; DRUG ELUTING STENT; EVIDENCE BASED MEDICINE; FEMOROPOPLITEAL BYPASS; HUMAN; IMPLANT REGISTRY; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; LEG ISCHEMIA; PATIENT SAFETY; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; STENT; SUPERFICIAL FEMORAL ARTERY; SURGICAL EQUIPMENT; TREATMENT OUTCOME; TREATMENT PLANNING;

ARTERIAL OCCLUSIVE DISEASES; CONSTRICTION, PATHOLOGIC; DATA INTERPRETATION, STATISTICAL; DEVICE APPROVAL; DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; EVIDENCE-BASED MEDICINE; FEMORAL ARTERY; HUMANS; POPLITEAL ARTERY; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RESEARCH DESIGN; STENTS; TREATMENT OUTCOME;

EID: 77956335938     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2010.05.001     Document Type: Article

References (64)

1. Ansel G.M., Lumsden A.B. Evolving modalities for femoropopliteal interventions. J Endovasc Ther 2009, 16:II82-II97.
2. Bosiers M., Deloose K., Verbist J., Peeters P. Present and future of endovascular SFA treatment: stents, stent-grafts, drug coated balloons and drug coated stents. J Cardiovasc Surg (Torino) 2008, 49:159-165.
3. Nguyen M.C., Garcia L.A. Recent advances in atherectomy and devices for treatment of infra-inguinal arterial occlusive disease. J Cardiovasc Surg (Torino) 2008, 49:167-177.
4. Arena F.J. Arterial kink and damage in normal segments of the superficial femoral and popliteal arteries abutting nitinol stents-a common cause of late occlusion and restenosis?. A single-center experience. J Invasive Cardiol 2005, 17:482-486.
5. Kandzari D.E., Kiesz R.S., Allie D., et al. Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia. J Endovasc Ther 2006, 13:12-22.
6. Laird J.R. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 2006, 13(suppl 2):II30-II40.
7. Klinkert P., Post P.N., Breslau P.J., van Bockel J.H. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 2004, 27:357-362.
8. Dormandy J.A., Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000, 31:S1-S296.
9. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007, 33(suppl 1):S1-S75.
10. Lyden S.P., Smouse H.B. TASC II and the endovascular management of infrainguinal disease. J Endovasc Ther 2009, 16:II5-II18.
11. Mewissen M.W. Stenting in the femoropopliteal arterial segment. Tech Vasc Interv Radiol 2005, 8:146-149.
12. Schillinger M., Exner M., Mlekusch W., et al. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries. Radiology 2002, 224:529-535.
13. Schlager O., Dick P., Sabeti S., et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 2005, 12:676-684.
14. Lyden S.P., Shimshak T.M. Contemporary endovascular treatment for disease of the superficial femoral and popliteal arteries: an integrated device-based strategy. J Endovasc Ther 2006, 13(suppl 2):II41-II51.
15. Mewissen M.W. Primary nitinol stenting for femoropopliteal disease. J Endovasc Ther 2009, 16:II63-II81.
16. Sabeti S., Schillinger M., Amighi J., et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004, 232:516-521.
17. Minar E., Schillinger M. New stents for SFA. J Cardiovasc Surg (Torino) 2009, 50:635-645.
18. Saxon R.R., Coffman J.M., Gooding J.M., Ponec D.J. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol 2007, 18:1341-1349. quiz 1350.
19. Saxon R.R., Dake M.D., Volgelzang R.L., Katzen B.T., Becker G.J. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008, 19:823-832.
20. Bosiers M., Cagiannos C., Deloose K., Verbist J., Peeters P. Drug-eluting stents in the management of peripheral arterial disease. Vasc Health Risk Manag 2008, 4:553-559.
21. Foo R.S., Gershlick A.H., Hogrefe K., et al. Inhibition of platelet thrombosis using an activated protein C-loaded stent: in vitro and in vivo results. Thromb Haemost 2000, 83:496-502.
22. Jeong M.H., Owen W.G., Staab M.E., et al. Porcine model of stent thrombosis: platelets are the primary component of acute stent closure. Cathet Cardiovasc Diagn 1996, 38:38-43.
23. Mousa A., Rhee J.Y., Trocciola S.M., et al. Percutaneous endovascular treatment for chronic limb ischemia. Ann Vasc Surg 2005, 19:186-191.
24. Strecker E.P., Boos I.B., Gottmann D., Vetter S. Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1- and 2-year results. Eur Radiol 2004, 14:302-308.
25. Black J.H., LaMuraglia G.M., Kwolek C.J., Brewster D.C., Watkins M.T., Cambria R.P. Contemporary results of angioplasty-based infrainguinal percutaneous interventions. J Vasc Surg 2005, 42:932-939.
26. Conrad M.F., Cambria R.P., Stone D.H., et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 2006, 44:762-769.
27. Dosluoglu H.H., Wang J., Defranks-Anain L., Rainstein M., Nader N.D. A simple subclassification of American Society of Anesthesiology III patients undergoing peripheral revascularization based on functional capacity. J Vasc Surg 2008, 47:766-772. discussion 722-723.
28. Davies M.G., Saad W.E., Peden E.K., Mohiuddin I.T., Naoum J.J., Lumsden A.B. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg 2008, 48:619-625. discussion 625-626.
29. Galaria I.I., Surowiec S.M., Rhodes J.M., et al. Percutaneous and open renal revascularizations have equivalent long-term functional outcomes. Ann Vasc Surg 2005, 19:218-228.
30. Ansel G.M., Botti C.F., George B.S., Kazienko B.T. Clinical results for the training-phase roll-in patients in the Intracoil femoralpopliteal stent trial. Catheter Cardiovasc Interv 2002, 56:443-449.
31. Jahnke T., Voshage G., Muller-Hulsbeck S., Grimm J., Heller M., Brossmann J. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. J Vasc Interv Radiol 2002, 13:257-266.
32. Treiman G.S., Whiting J.H., Treiman R.L., McNamara R.M., Ashrafi A. Treatment of limb-threatening ischemia with percutaneous intentional extraluminal recanalization: a preliminary evaluation. J Vasc Surg 2003, 38:29-35.
33. Tepe G., Schmehl J., Heller S., Wiesinger B., Claussen C.D., Duda S.H. Superficial femoral artery: current treatment options. Eur Radiol 2006, 16:1316-1322.
34. Wiesinger B., Heller S., Schmehl J., Claussen C.D., Wiskirchen J., Tepe G. Percutaneous vascular interventions in the superficial femoral artery. A review. Minerva Cardioangiol 2006, 54:83-93.
35. Alimi Y.S., Hakam Z., Hartung O., et al. Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?. Eur J Vasc Endovasc Surg 2008, 35:346-352.
36. Farraj N., Srivastava A., Pershad A. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft. J Invasive Cardiol 2009, 21:278-281.
37. Fischer M., Schwabe C., Schulte K.L. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther 2006, 13:281-290.
38. Verta M.J., Schneider J.R., Alonzo M.J., Hahn D. Percutaneous Viabahn-assisted subintimal recanalization for severe superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008, 19:493-498.
39. Laird J: Lessons learned in RESILIENT Trial-interview. Endovas Today October:59-62, 2008.
40. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006, 354:1879-1888.
41. Schillinger M., Sabeti S., Dick P., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007, 115:2745-2749.
42. Krankenberg H., Schluter M., Steinkamp H.J., et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007, 116:285-292.
43. Das T.S., Beregi J.P., Garcia L.A., et al. Infrainguinal lesion-specific device choices: round-table discussion. J Endovasc Ther 2006, 13(suppl 2):II60-II71.
44. Duda S.H., Pusich B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002, 106:1505-1509.
45. Duda S.H., Bosiers M., Lammer J., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005, 16:331-338.
46. Scheinert D., Scheinert S., Sax J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005, 45:312-315.
47. Schillinger M., Minar E. Past, present and future of femoropopliteal stenting. J Endovasc Ther 2009, 16(suppl 1):I147-I152.
48. Zhang F., Dong L., Ge J. Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: a meta-analysis of randomised trials. Heart 2009, 95:1676-1681.
49. Butt M., Connolly D., Lip G.Y. Drug-eluting stents: a comprehensive appraisal. Future Cardiol 2009, 5:141-157.
50. Duda S.H., Bosiers M., Lammer J., et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006, 13:701-710.
51. Dake M: The Zilver PTX global registry and RCT (interview). Endovasc Today October:63-64, 2008.
52. Bunk D. Drug-eluting stent proves durable at 6- and 12-month follow-up. Am Coll Surg Surg News 2008, 4:12.
53. Marin M.L., Veith F.J., Cynamon J., et al. Transfemoral endoluminal repair of a penetrating vascular injury. J Vasc Interv Radiol 1994, 5:592-594.
54. Marin M.L., Veith F.J., Cynamon J., et al. Initial experience with transluminally placed endovascular grafts for the treatment of complex vascular lesions. Ann Surg 1995, 222:449-465. discussion 465-459.
55. Marin M.L., Veith F.J., Panetta T.F., et al. Transluminally placed endovascular stented graft repair for arterial trauma. J Vasc Surg 1994, 20:466-472. discussion 472-483.
56. Kedora J., Hohmann S., Garrett W., Munschaur C., Theune B., Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007, 45:10-16. discussion 16.
57. Verta M.J., Schneider J.R., Alonzo M., Hahn D. Percutaneous viabahn-assisted subintimal recanalization (VASIR) for severe femoropopliteal occlusive disease. Acta Chir Belg 2007, 107:181-186.
58. Lammer J., Dake M.D., Bleyn J., et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology 2000, 217:95-104.
59. McQuade K., Gable D., Hohman S., Pearl G., Theune B. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2009, 49:109-115. 116 e1-9; discussion 116.
60. Mewissen M: Single center and multicenter results (VIBRANT Trial) of Viabahn stent-graft vs. uncovered nitinol stent for SFA occlusive disease: how to rescue occluded stents and stent-grafts (the SALVAGE study). Abstract presented at the VEITH Symposium, November 20, 2008, New York, NY.
61. Begovac P.C., Thomson R.C., Fisher J.L., Hughson A., Gallhagen A. Improvements in GORE-TEX vascular graft performance by Carmeda BioActive surface heparin immobilization. Eur J Vasc Endovasc Surg 2003, 25:432-437.
62. Heyligers J.M., Verhagen H.J., Rotmans J.I., et al. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. J Vasc Surg 2006, 43:587-591.
63. Battaglia G., Tringale R., Monaca V. Retrospective comparison of a heparin bonded ePTFE graft and saphenous vein for infragenicular bypass: implications for standard treatment protocol. J Cardiovasc Surg (Torino) 2006, 47:41-47.
64. Lin P.H., Chen C., Bush R.L., Yao Q., Lumsden A.B., Hanson S.R. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. J Vasc Surg 2004, 39:1322-1328.